Mulmit

Annovis Bio, Inc.Annovis Bio, Inc.

ANVS NYSE

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-310-29,695,258-28,854,197-1.4
2024-12-310-26,694,928-24,590,375-2.31
2023-12-310-45,035,011-56,204,313-6.23
2022-12-310-25,511,279-25,328,567-3.1
2021-12-310-14,537,221-14,487,132-1.9

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-05-20Hoffman Michael B2,562
2026-05-20Hoffman Michael B18,849
2026-05-20Hoffman Michael B54,933
2026-04-02Hoffman Michael B713,800
2025-12-08Hoffman Michael B30,000
2025-12-08Hoffman Michael B15,000
2025-11-24Hoffman Michael B1,489
2025-11-24Hoffman Michael B9,200
2025-11-24Hoffman Michael B415
2025-11-24Hoffman Michael B28,096
2025-11-21Hoffman Michael B10,000
2025-11-21Hoffman Michael B10,000

8-K events

FiledItems
2026-08-14Results of operations · Financial statements and exhibits
2026-07-10Other events · Financial statements and exhibits
2026-06-17Submission of matters to a vote · Financial statements and exhibits
2026-05-20Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
2026-05-15Results of operations · Financial statements and exhibits
2026-04-10Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
2026-03-25Officer or director change · Financial statements and exhibits
2026-03-16Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…